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https://doi.org/10.1016/j.molcel.2020.12.004SUMMARYEukaryotic cells regulate 50-triphosphorylated RNAs (ppp-RNAs) to promote cellular functions and prevent
recognition by antiviral RNA sensors. For example, RNA capping enzymes possess triphosphatase domains
that remove the g phosphates of ppp-RNAs during RNA capping. Members of the closely related PIR-1
(phosphatase that interacts with RNA and ribonucleoprotein particle 1) family of RNA polyphosphatases re-
move both the b and g phosphates from ppp-RNAs. Here, we show that C. elegans PIR-1 dephosphorylates
ppp-RNAsmade by cellular RNA-dependent RNA polymerases (RdRPs) and is required for the maturation of
26G-RNAs, Dicer-dependent small RNAs that regulate thousands of genes during spermatogenesis and
embryogenesis. PIR-1 also regulates the CSR-1 22G-RNA pathway and has critical functions in both somatic
and germline development. Our findings suggest that PIR-1 modulates both Dicer-dependent and Dicer-in-
dependent Argonaute pathways and provide insight into how cells and viruses use a conserved RNA phos-
phatase to regulate and respond to ppp-RNA species.INTRODUCTION
Cells canmodify and sense the phosphorylation status of RNA 50
ends to regulate gene expression, control RNA stability, and
mediate antiviral defense (Hornung et al., 2006; Kato et al.,
2006; Shatkin, 1976). For example, the eukaryotic RNA polymer-
ase II recruits a capping enzyme that co-transcriptionally mod-
ifies the 50 end of its RNA products. A key enzymatic modality
in this capping enzyme is an RNA triphosphatase domain related
to the cysteine phosphatase superfamily of protein and RNA
phosphatases (Deshpande et al., 1999; Takagi et al., 1998;
Yuan et al., 1998). After removing the g phosphate from a
nascent transcript, capping enzyme installs a guanine-nucleo-
tide cap that masks the 50 end from cellular nucleases and sen-
sors that recognize RNAs made by viral polymerases (Shatkin,
1976). Cellular and viral homologs of the triphosphatase domain
of capping enzymes include the PIR-1 (phosphatase that inter-
acts with RNA and ribonucleoprotein particle 1) family of RNA
polyphosphatases, which catalyze the removal of g and b phos-
phates from 50-triphosphorylated RNAs (ppp-RNAs) in vitro
(Deshpande et al., 1999; Takagi et al., 1998; Yuan et al., 1998).546 Molecular Cell 81, 546–557, February 4, 2021 ª 2020 Elsevier IncHowever, the cellular functions and targets of PIR-1 are largely
unknown.
The C. elegans PIR-1 homolog was identified as a binding
partner of the RNA interference (RNAi) factor Dicer (Duchaine
et al., 2006). RNAi plays important roles in regulating gene
expression and viral immunity in diverse organisms (Baulcombe,
2004; Hannon, 2002; McCaffrey et al., 2002). Dicer encodes a
multifunctional protein with double-stranded RNA (dsRNA)-
binding motifs, a DExH/D helicase motif, and a bidentate RNase
III domain (Macrae et al., 2006). Dicer is known to bind and then
process dsRNAs into short-interfering RNAs (siRNAs) or micro-
RNAs (miRNAs) that guide Argonaute co-factors to mediate ge-
netic silencing (Bernstein et al., 2001; Grishok et al., 2001).
In vitro studies suggest that Dicer is not sensitive to the 50 phos-
phorylation status of its substrates (Welker et al., 2011), raising
the question of how and why Dicer associates with PIR-1.
In C. elegans, Dicer (DCR-1) functions in several small RNA
pathways, including the miRNA pathway and the endogenous
RNAi (endo-RNAi) and exogenous RNAi (exo-RNAi) pathways
triggered by dsRNAs (Duchaine et al., 2006; Grishok et al.,
2001; Welker et al., 2010). Upon exposure to exogenous or viral.
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siRNAs with monophosphorylated 50 ends and 30 2-nt overhangs
(Ashe et al., 2013; Coffman et al., 2017; Guo et al., 2013). These
diced siRNAs are loaded onto the Argonaute RDE-1 (Tabara
et al., 1999), which cannot silence targets alone (Gu et al.,
2009; Steiner et al., 2009; Yigit et al., 2006). Instead, RDE-1 re-
cruits cellular RNA-dependent RNA polymerases (RdRP) to
generate or amplify the silencing signal (Pak and Fire, 2007; Yigit
et al., 2006). These RdRPs prefer to initiate transcription at C res-
idues located 50 of a purine on template RNAs and thus produce
22-nt products that contain a 50-triphosphorylated (ppp-)G resi-
due, so-called 22G-RNAs (Claycomb et al., 2009; Gu et al., 2012;
Pak and Fire, 2007). 22G-RNAs are then loaded onto worm-spe-
cific Argonautes (WAGOs) (Gu et al., 2009). Unlike other Argo-
nautes, which usually bind monophosphorylated RNA (p-RNA)
guides, WAGOs directly accommodate the ppp-RNA guides
synthesized by RdRP (Gu et al., 2009).
In addition to its key role in the exo-RNAi pathway, DCR-1 also
functions in endogenous small RNA pathways (Duchaine et al.,
2006; Fire et al., 1998; Grishok et al., 2001; Ruby et al., 2006;
Welker et al., 2010). Several genes that function in nonessential
endo-RNAi pathways were identified as mutants with enhanced
exo-RNAi (ERI mutants), perhaps because these endo-RNAi
pathways compete for downstream components that are limiting
for robust exo-RNAi (Duchaine et al., 2006; Fischer et al., 2011;
Kennedy et al., 2004; Simmer et al., 2002). The ERI genes and
their associated factors define two major endo-RNAi pathways,
both of which employ 26-nt antisense RNAs that usually start
with G (26G-RNAs). The ERGO-1 Argonaute and two redundant
Argonautes, ALG-3 and ALG-4 (ALG-3/4), engage 26G-RNAs
during embryogenesis and spermatogenesis, respectively, and
like RDE-1 can trigger the biogenesis of the RdRP-mediated
WAGO-dependent 22G-RNAs (Conine et al., 2010; Gent et al.,
2010; Han et al., 2009; Vasale et al., 2010; Zhang et al., 2011).
Interestingly, 26G-RNAs are also RdRP products themselves,
but unlike 22G-RNAs, 26G-RNAs are monophosphorylated
and are processed by Dicer in the context of the Dicer-ERI pro-
tein complex (Duchaine et al., 2006; Thivierge et al., 2011). Pre-
cisely how 26G-RNAs are processed by the Dicer-ERI complex
and how 26G-RNAs acquire their 50 monophosphorylated state
are largely unknown.
TheCSR-1 Argonaute, which has been proposed to promote or
modulate rather than silence germline gene expression (Kirino
and Mourelatos, 2007; Langmead et al., 2009; Lee et al., 2010,
2012; Seth et al., 2013), engages 22G-RNAs targeting themajority
of germline-expressedmRNAs, includingmany spermatogenesis
mRNAs regulated by the ALG-3/4 26G-RNA pathway (Conine
et al., 2010, 2013; Han et al., 2009). However, the vast majority
of mRNAs targeted by CSR-1 22G-RNAs are expressed outside
of spermatogenesis (Claycomb et al., 2009), and 26G-RNAs tar-
geting these non-spermatogenesis CSR-1 targets have not
been identified. Thus, it is not known whether 26G-RNAs and
Dicer regulate non-spermatogenesis CSR-1 22G-RNAs.
Here, we show that C. elegans PIR-1 is an RNA polyphospha-
tase required for germline development and endogenous small
RNA pathways. pir-1mutants exhibit not only a strong depletion
of 22G-RNA species that depend on ALG-3/4 for their amplifica-
tion but also a striking more than 2-fold reduction in nearly allCSR-1 22G-RNAs. Recombinant PIR-1, like its vertebrate and
viral homologs, removes g and b phosphates from ppp-RNAs.
Catalytically dead PIR-1 binds ppp-RNAs, but not p-RNAs,
in vitro. Null and catalytically dead pir-1mutants exhibit dramat-
ically delayed larval development and male and hermaphrodite
infertility. PIR-1 copurifies with the DCR-1-ERI complex and
PIR-1 activity is essential to make ERI-dependent 26G-RNAs
that engage ALG-3/4. Our analyses suggest a model whereby
26G-RNAs are made in a unique phased manner by successive
rounds mRNA processing by the Dicer-ERI complex and that
PIR-1 promotes this mechanism by removing a diphosphate
group from the 50 end of 26G-RNA precursors, likely to facilitate
loading into Argonautes. Our findings implicate PIR-1 as a regu-
lator of endogenous Argonaute pathways that process their
small-RNA co-factors from RdRP products.
RESULTS
C. elegans PIR-1 is an RNA polyphosphatase
Previous studies have shown that vertebrate and viral homologs
of PIR-1 have polyphosphatase activity that depends on a
conserved cysteine in the catalytic motif HCX5RXG (Figure 1A;
Deshpande et al., 1999; Takagi et al., 1998; Yuan et al., 1998).
To characterize the enzymatic activity of C. elegans PIR-1, we
purified recombinant wild-type (WT) PIR-1 protein, as well as re-
combinant mutant PIR-1(C150S), in which the catalytic cysteine
is replaced with serine (Figure S1A). We then incubated ppp-
RNAs with these proteins and assessed the 50 phosphorylation
status of reaction products using Terminator exonuclease, which
degrades 50 p-RNA, but not diphosphorylated RNAs (pp-RNAs)
or ppp-RNAs. WT PIR-1, but not PIR-1(C150S), efficiently con-
verted ppp-RNAs into substrates that were degraded by Termi-
nator exonuclease, including substrates ranging in size from 26
to 110 nt (Figures 1B and S1B).WT PIR-1 also dephosphorylated
ppp-RNAs duplexed with RNA or DNA (Figures 1C and S1C).
Notably, PIR-1(C150S), but not WT PIR-1 protein, remained
bound to ppp-RNA, but not p-RNA, substrates in electrophoretic
mobility shift assays (Figures 1D and S1D); this shift was caused
by PIR-1(C150S) rather than by contamination, as confirmed by
western blot analyses (Figure 1E). This mobility shift was de-
tected using 50 mM Tris-Cl buffer (pH 8.0), but not when native
protein gel buffer containing 25 mM Tris and 192 mM glycine
(pH 8.3) was used (Figure S1E), indicating that PIR-1(C150S)
binds ppp-RNA non-covalently. Thus, like its vertebrate and viral
homologs, PIR-1 is an RNA polyphosphatase that converts ppp-
RNA to p-RNA.WhereasWT PIR-1 rapidly releases p-RNA prod-
ucts, the catalytically dead PIR-1(C150S) selectively binds and
remains bound to ppp-RNA substrates.
PIR-1 associates with the ERI complex
C. elegans PIR-1 was previously identified as a DCR-1-interact-
ing protein (Duchaine et al., 2006). To characterize PIR-1 com-
plexes, we performed PIR-1 immunoprecipitation (IP) and
analyzed the immunoprecipitates usingmultidimensional protein
identification technology (MudPIT; Wolters et al., 2001). To facil-
itate the identification of proteins that specifically interact with
PIR-1, we rescued a pir-1(tm3198) null mutant with a pir-1::gfp




Figure 1. PIR-1 is anRNApolyphosphatase
(A) Alignment of PIR-1 orthologs from C. elegans
(C.e.), Drosophila (D.m.), and human (H.s.);
asterisk indicates the catalytic cysteine.
(B) Terminator exonuclease assays on ppp-RNA
substrates with and without pretreatment by WT
or C150S recombinant PIR-1.
(C) Terminator exonuclease assays on ppp-RNA
duplexed with DNA and RNA (left: schematic of
pretreatments).
(D) Gel-shift assays on single-stranded ppp-RNA
and p-RNA substrates using recombinant WT
and C150S PIR-1, visualized by 15% native
PAGE and SYBR gold staining.
(E) Gel-shift assays followed by SYBR gold
staining (left) and western blot (for detection of
His-tagged WT and C150S PIR-1 [right]) on RNA
substrates (as indicated).
See also Figure S1.
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Article(14N). In parallel, we labeled control WT worms with heavy nitro-
gen (15N). We then mixed 14N-labeled pir-1::gfp worms with an
equal number of 15N-labeled control worms, prepared worm
lysates, and immunoprecipitated PIR-1::GFP using anti-GFP an-









PIR-1 233 100 47.2%
DCR-1 1910 115 22.3%
RRF-3 1765 63 21.8%
DRH-3 1119 52 26.2%
ERI-3 (W09B6.3a)b 578 24 16.1%
RDE-4 385 16 19.0%
ERI-1 (T07A9.5b)b 582 12 13.1%
ERI-5 (Y38F2AR.1a)b 531 11 11.9%
aThe number of tandem mass spectra matching peptides derived from
each protein.
bOnly the isoform with the most counts is shown.
548 Molecular Cell 81, 546–557, February 4, 2021and identified candidate PIR-1 interac-
tors as proteins with a minimum of 10
spectral counts for 14N-labeled peptides
and no spectral counts for 15N-labeled
peptides. These studies revealed that
PIR-1 interacts with the core proteins of
the ERI complex (Tables 1 and S1; Ken-
nedy et al., 2004; Pavelec et al., 2009;
Simmer et al., 2002; Thivierge et al.,
2011; Timmons, 2004). Similar results
were obtained using a pir-1::3 3 flag-
rescued strain with FLAG IP (Table S1).
Using western blot analyses, we
confirmed that DCR-1, DRH-3, RRF-3,
ERI-1b, and RDE-8 interact with PIR-1at all developmental stages (Figures 2A, 2B, and S2A). PIR-1
did not coimmunoprecipitate with ERI-1a (Figure 2A), an isoform
of ERI-1 known to processes the 30 end of 5.8S rRNA (Gabel and
Ruvkun, 2008). Several Argonaute-dependent small RNA
pathway factors that are not part of the ERI complex, including
the 30-to-50 exonuclease MUT-7, the RdRPs RRF-1 and EGO-
1, and the Argonautes CSR-1 and WAGOs, were not detected
in PIR-1 immunoprecipitates (Figures 2A, 2B, and S2A; Tables
1 and S1). These western blot studies identified two PIR-1 iso-
forms, PIR-1a and PIR-1b, which differ in size by ~2–4 kDa on
denaturing polyacrylamide gels (Figures 2 and S2). The molecu-
lar basis for this difference remains to be identified. Both iso-
forms were detected at all larval and adult stages. However,
only PIR-1b was detected in embryos, where it associated with
several components of the ERI complex (Figure 2B). The associ-
ation of PIR-1b with the ERI complex was confirmed by gel
filtration chromatography in which PIR-1b associated with a
>440-kDa complex that included DCR-1, DRH-3, ERI-1b, and
RDE-8 (Figure 2C; (Thivierge et al., 2011). Genetic analyses re-
vealed that the interaction between PIR-1 and the ERI complex
depends on DCR-1 and DRH-3, but not on ERI-1 or RDE-4 (Fig-
ures S2B–S2D). As expected, reciprocal IP of DRH-3 or DCR-1
pulled down PIR-1 (Figure S2E; Duchaine et al., 2006; Gu
A B
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Figure 2. PIR-1 interacts with the ERI
complex
(A) Western blot analyses on WT (N2) and pir-
1::3xflag-rescued young adults showing proteins
present in input (lysate), FLAG IP, and post-IP
supernatant. Asterisks indicate unspecified
bands.
(B) Western blot analyses of PIR-1-associated
proteins across developmental stages in N2 and
PIR-1::3xFLAG (left) and PIR-1::GFP lysates (as
indicated). Asterisk indicates a background signal
that co-migrates with tubulin from binding of the
secondary antibody to the heavy chain of the anti-
FLAG antibody.
(C) Gel-filtration analysis of pir-1::3xflag lysates
followed by western blot analyses (as indicated).
Arrowheads indicate molecular weights of size
standards.
See also Figure S2 and Tables 1 and S1.
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by GFP IP, appeared to depend on drh-3(+) activity, while PIR-
1b::GFP expression required dcr-1(+) activity (Figures S2B
and S2C).
PIR-1 is an essential protein broadly localized to nucleus
and cytoplasm
A previous study identified PIR-1 as a Dicer interactor and
described a mutation, pir-1(tm1496), which causes a fully pene-
trant larval lethal phenotype at the early L4 stage (Duchaine et al.,
2006). The tm1496 deletion also removes the promoter and part
of the neighboring essential gene sec-5 (Figure 3A), perhaps
contributing to the early L4 arrest phenotype. To further explore
the function of PIR-1, we generated a second deletion allele
(tm3198) and a catalytic C150S mutant allele (wg1000; Fig-
ure 3A). These new alleles caused identical fully penetrant phe-
notypes. Homozygotes matured more slowly than WT animals,
arresting at late larval and adult stages, and were invariably ster-
ile (Figure 3; see below). The tm3198 allele deletes the first intron
and most of the second exon of pir-1 (Figure 3A), which is ex-
pected to shift the pir-1 open reading frame and causes prema-
ture translation termination. Moreover, the lethal phenotypes
associated with tm3198 were fully rescued by a single-
copy pir-1::gfp fusion gene driven by the pir-1 promoter and 30
UTR, indicating that the tm3198 phenotypes result from loss of
pir-1(+) activity.
Analysis of PIR-1::GFP revealed nuclear and cytoplasmic
staining in most germline and somatic cells (Figures 3B, S3A,
and S3B). In the germlines of L4-stage hermaphrodite worms
(i.e., during spermatogenesis), PIR-1::GFP was uniformly pre-Molecusent in germ cells from the proliferative
mitotic zone to the meiotic mid-pachy-
tene region (Figure 3B). PIR-1::GFP
fluorescence was reduced in germ
cells transitioning through diplotene and
meiosis I and II (i.e., through the bend in
the ovotestis) and then increased again
just before cells begin spermatogenesis.In adult hermaphrodites (i.e., during oogenesis), we detected
PIR-1::GFP in the distal germline and through the bend in the
ovotestis, but we did not detect PIR-1::GFP signal in maturing
oocytes or the embryonic germline. PIR-1::GFP fluorescence
was detected in most somatic nuclei throughout development,
exhibiting the highest level in the large polyploid nuclei of intes-
tinal cells (Figure S3A).
The majority of tm3198 homozygotes (64%) arrested as sterile
adults (Figure S3C), frequently with a protruding vulva and occa-
sionally ruptured at the vulva (Figures 3C and S3D). Approxi-
mately 21% of worms made deformed oocytes, but none
made progeny (Figure S3D). Approximately one-quarter of
tm3198 animals arrested as viable L4-like larvae that survived
for nearly a normal lifespan with apparently normal motility.
Close examination of the germlines of these L4-like arrested
larvae revealed features typical of normal L4 germline, including
a mitotic zone, a transition zone, an extended zone of meiotic
nuclei undergoing pachytene, and a spermatogenic zone,
including spermatocytes and spermatids (Figure 3D). A PGL-
1::RFP reporter was localized in a WT pattern throughout the
distal germline, but not in the proximal spermatogenic region
of these arrested L4-like worms, suggesting that they transi-
tioned properly to spermatogenic gene expression (Figure 3E).
We noticed that many dividing spermatocytes in pir-1 germlines
exhibited abnormal meiotic figures indicative of DNA bridging
(Figure 3F). Similar defects were previously described for mu-
tants in ERI components. For example, loss-of-function muta-
tions in rrf-3, eri-1, and eri-3 and the helicase-domain mutant
dcr-1(mg375) have all been reported to cause similar DNA-






Figure 3. PIR-1 is essential for somatic and
germline development
(A) Schematic of the pir-1 locus indicating genetic
lesions used.
(B) Schematic of a rescuing transgene with GFP
exons indicated in green (top panel) and fluores-
cence micrographs of an L4 germline stained with
DAPI and anti-GFP (bottom panels).
(C) DIC images of a pir-1(+/tm3198) heterozygote
and an arrested tm3198 homozygote cultured at
20C for 96 h, with germlines indicated by yellow
highlighting (partly concealed by intestine).
(D–F) Fluorescence micrographs of WT (N2)
and mutant germlines visualized by DAPI (D–F)
and PGL-1::RFP fluorescence (E). Distal germline
is oriented to the left. m, mitotic zone; tz, transi-
tion zone; p, pachytene; sp, spermatids (D).
Abnormal chromosome bridging is indicated by
red arrows (F).
See also Figure S3.
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ArticleERI pathway mutants all make defective spermatids (Conine
et al., 2010; Han et al., 2009; Simmer et al., 2002). To summarize,
pir-1 mutants exhibit a spectrum of defects at larval and adult
stages similar to, and in some respects (such as the larval arrest
and oogenesis defects) more severe than, other Dicer-ERI com-
plex co-factors.
PIR-1 is not required for miRNA or Piwi-interacting RNA
(piRNA) biogenesis
We next explored how pir-1 mutations affect endogenous small
RNA levels. To obtain large numbers of pir-1 homozygotes, we
used a strategy to select against heterozygotes in which pir-1 is
covered by the inversion balancer mnC1. Three redundant gluta-
mate-gated chloride channels (AVR-14, AVR-15, and GLC-1)
render C. elegans sensitive to the nematocidal drug ivermectin
(Dent et al., 2000). We crossed pir-1 into an avr-14(ad1302); avr-
15(ad1051); glc-1(pk54) triple mutant (avr3x) background and
balanced pir-1with anmnC1 balancer that also carries a rescuing
avr-15(+) transgene (Table S2). In the presence of ivermectin, the
pir-1/mnC1 heterozygotes (expressing AVR-15) arrest as L1
larvae, but pir-1 homozygotes (not expressing AVR-15) grow to
late larval stages and adulthood. We grew synchronized popula-
tions of pir-1 homozygous or control (avr3x or N2) worms to
extract RNA and generate small RNA libraries for high-throughput
sequencing (see STAR methods). We noted that pir-1 mutants
grew more slowly, both in size and developmental landmarks
(e.g., adult cuticle and vulval differentiation), sowe prepared sam-
ples from pir-1 mutants grown for 3 days or for 7 days to attain
parity in developmental stage with WT populations. To obtain a
snapshot of all the different classes of Argonaute-associated
small RNAs, we pretreated the small RNA samples with tobacco
acid pyrophosphatase (TAP) or purified recombinant PIR-1 pro-550 Molecular Cell 81, 546–557, February 4, 2021tein, both of which convert ppp-RNAs to
p-RNAs. This approach allowed us to
simultaneously recover p-RNAs (26G-
RNAs, miRNAs, and piRNA/21U-RNAs)
and ppp-RNAs (22G-RNAs).Analysis of the small RNA sequencing data revealed that
miRNA and piRNA species were largely unaffected in pir-1 mu-
tants (Figure 4A). Comparing small RNAs from temporally
matched pir-1 and control populations (i.e., pir-1 and avr3x on
ivermectin for 3 days), we found that pir-1(tm3198) expressed
more miRNAs but fewer piRNAs and 22G-RNAs (when normal-
ized to total genomemapping reads, including all authentic small
RNA species). These findings are likely caused by the develop-
mental delay of pir-1(tm3198) worms that causes a relatively
smaller germline-to-soma ratio in the 3-day-old pir-1 worms, ar-
tificially enriching miRNAs, since miRNAs are abundant in the
soma, whereas 21U-RNAs and most 22G-RNAs are expressed
in the germline (Figure 4A). Consistent with this idea, in 7-day-
old pir-1(tm3198) animals, which appear developmentally similar
to 3-day-old WT or avr3x worms, piRNAs and miRNAs were
increased to a similar level and in proportion to the correspond-
ing decrease in 22G-RNA levels (Figure 4A). Moreover,
developmentally matched (7-day-old) pir-1 and control (3-day-
old) avr3x worms expressed similar levels of DCR-1 and
PRG-1 proteins, factors required for generating miRNAs and
binding piRNAs, respectively. These observations suggest
that the biogenesis of miRNAs and 21Us is temporally delayed
in pir-1 mutants but is not likely to be directly regulated by
PIR-1(+) activity (Figure 4B). Indeed, when we normalized our
small RNA data to piRNA levels, we observed similar levels of
miRNAs in control worms and developmentally matched pir-1
mutants, but 22G-RNA levels were significantly lower in pir-1
worms (Figure 4C). Thus, pir-1 mutants do not exhibit defects
in miRNA levels, consistent with our finding that the seam cell
numbers (16 on each side of the worm) and adult alae differenti-





Figure 4. PIR-1 is required for the biogen-
esis of 26G-RNAs and non-WAGO-bound
22G-RNAs
(A) Venn diagrams showing relative abundance of
small RNA species in pir-1(tm3198) mutants and
control avr3x animals. For each strain, small RNA
composition was calculated as the average of two
replicas.
(B) Western blot analyses of DCR-1 and PRG-1 in
control avr3x and pir-1 mutants, normalized to
tubulin.
(C and D) Bar graphs comparing abundance of
small RNA species in reads per million (RPM) in
arrested pir-1 mutants (7 days old) and L4 stage
avr3x animals (as indicated). The error bar repre-
sents one standard error. p values were calculated
for two replicas using unpaired Student’s t test
(one-tailed for 22G-RNAs and 26G-RNAs and two-
tailed for miRNA). In (D), ‘‘n’’ indicates the number
of target genes in each category.
(E) Histogram showing ratios of 22G-RNAs (pir-1/
pir-1 + control avr3x) (x axis) calculated for each
individual gene in the two CSR-1 target categories
and binned into 20 intervals plotted against fre-
quency for each ratio (y axis).
See also Figure S4 and Table S3.
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Among themost dramatically affected small RNA species in pir-1
mutants were 26G-RNAs that depend on the ALG-3/4 Argo-
nautes. These 26G-RNAs are templated from the mRNAs of
1,683 target genes, including many genes that play critical roles
during spermatogenesis (Table S3; Conine et al., 2010). We
found that 26G-RNAs were ~10-fold less abundant in pir-1 mu-
tants than in WT populations (normalized to 21U-RNA levels;
one-tailed t test, p < 0.005; Figures 4D and S4A). Moreover,
22G-RNAs that are amplified downstream of ALG-3/4 targeting
(Conine et al., 2010) were also significantly lower in pir-1mutants
(~2.4-fold; one-tailed t test, p < 0.0029; Figures 4D and S4B).
ALG-3/4-independent WAGO 22G-RNAs were not significantly
downregulated in pir-1 mutants (one-tailed t test, p < 0.109, or
two-tailed p < 0.218, Figures 4D and S4C; Conine et al., 2010;
Han et al., 2009; Pavelec et al., 2009).
All CSR-1-bound 22G-RNAs are reduced in pir-1
mutants
The CSR-1 Argonaute engages 22G-RNAs targeting thousands
of germline mRNAs. Roughly 11% of CSR-1 target genesMolecu(~423) are also targeted by the ALG-3/4-
dependent ERI pathway (Table S3; Con-
ine et al., 2010). However, most CSR-1
target genes have no known upstream
Argonautes. We found that compared to
WT worms, pir-1 mutants make signifi-
cantly (~3-fold) fewer 22G-RNAs for
both categories of CSR-1 target genes
(one-tailed t test, p < 0.034 and 0.033,
respectively; Figures 4D and S4D). Both
classes of CSR-1 22G-RNAs exhibitedsimilar ratios of reads in the mutant to total reads in the mutant
and WT (mutant/[mutant + WT]), with the same medians and
similar variances (Figure 4E). Moreover, both classes of CSR-1
22G-RNAs were significantly and dramatically reduced in the
pir-1(C150S) catalytic mutant (p < 0.01 or lower; Figure S4E).
We also observed a mild (~20%, same as the level in the
tm3198) but statistically significant reduction of WAGO 22G-
RNAs in the pir-1(C150S) mutant. Together, these results sug-
gest that the catalytic activity of PIR-1 is required for the biogen-
esis of CSR-1 small RNAs.
26G-RNAs are generated in a phased manner
26G-RNAs are unique among C. elegans small RNA species in
that their biogenesis depends on both RdRP and Dicer. Howev-
er, why they are longer than typical Dicer products and how their
50 ends becomemono- instead of triphosphorylated, as is typical
of other C. elegans RdRP products, remains mysterious. To
investigate the role of PIR-1 in 26G-RNA biogenesis, we used
bioinformatics to analyze the distribution patterns of small
RNAs associated with 26G-RNA target sites. To do this, we
compiled a metagene analysis of all available ALG-3/4 andlar Cell 81, 546–557, February 4, 2021 551
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Figure 5. Metagene analysis of 26G-RNA loci
(A and B) Bar graphs plotting small RNA levels across mRNA intervals that template 26G-RNAs in the ALG-3/4 (A) and ERGO-1 pathways (B). Frequencies of
mRNA-derived species (top) and RdRP-derived species (bottom) are plotted according to the position of their 50 nt. Length is color-coded. Coordinates are
defined relative to the C-nucleotide (1) used to template 26G production. RNA was prepared from (fog-2) male-enriched populations (A) or WT embryos (B).
See also Figure S5.
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ArticleERGO-1 26G-RNA target sequences centered on the 26G-RNA
and including ~40-nt upstream and downstream sequences. We
then analyzed small RNAs mapping to this interval, including
both antisense small RNAs (RdRP-derived) and sense small
RNAs (from mRNA cleavage). The frequency of each small
RNA species was plotted according to its 50 nt position and co-
lor-coded according to its length (Figures 5 and S5A). The posi-
tion of theC residue of themRNA corresponding to the 50 Gof the
antisense 26G-RNA was defined as 1. As expected, for both
ALG-3/4 and ERGO-1 26G-RNA pathways, the most abundant
antisense species were 26G-RNAs located at the 1 position
(Figures 5 and S5A). Consistent with a previous study (Blumen-
feld and Jose, 2016), this analysis revealed additional phased
26G-RNA peaks located at ~23-nt intervals upstream and down-
stream of 1 (Figures 5A and S5A). Mirroring the central and
phased 26G-RNAs, we observed an identical distribution pattern
of mRNA (i.e., sense-stranded) fragments that likely correspond
to Dicer products (Figures 5 and S5A). For the ALG-3/4 pathway,
most of these mRNA fragments were 22 nt long (sense 22-mer-
RNA) with their 50 ends at 23 and their 30 ends at 2, just up-
stream of the 1 C residue (Figure 5A and S5A). For the
ERGO-1 pathway, the most abundant sense-stranded small
RNAs were 19 nt long, with 50 ends at23 and 30 ends at5 (Fig-552 Molecular Cell 81, 546–557, February 4, 2021ure 5B). These findings suggest that associated nucleolytic ac-
tivities removes the 1 C residue (and a few additional nucleo-
tides for ERGO-1 templates) after it templates 26G-RNA
initiation (see Discussion). For both the ALG-3/4 and ERGO-1
pathways, the sense RNA 50 ends align 3 nt downstream of the
26G-RNA 30 ends. Taken together, these findings suggest that
the sense RNAs positioned at 23 in the metagene analysis
represent a signature of Dicer processing on duplex 26G-RNA
precursors (see Discussion).
The above analysis suggests that template mRNAs are pro-
cessed stepwise by RdRP and Dicer, with RdRP initiating at a C
residue and then reinitiating recursively at the first available C res-
idue after each Dicer cleavage event. We further tested this idea
by simulating 26G-RNA biogenesis on a computer-generated
transcriptome containing random RNA sequences and 26G-
RNA densities similar to those in our datasets. Simulated 26G-
RNAs were generated on targets by initiating at a randomly
selected C residue and then recursively at the first C residue at
least 23 nt upstream of the initial template C, propagating the
26G-RNA synthesis toward the 50 end of target mRNAs in a unidi-
rectional manner. Strikingly, this simulation produced exactly the
same metagene pattern observed in our experimental data,





Figure 6. pir-1 mutants are defective in
26G-RNA maturation
(A) Bar graph comparing the levels of antisense
26G-RNAs (located at 1 in the metagene space)
and sense-stranded 22-mers (located at 23)
cloned from of WT (avr3x), pir-1 null, and pir-
1(C150S), respectively. Small RNAs were cloned
using TAP or recombinant PIR-1 pretreatment to
prevent cloning bias against ppp-RNA species
(see STAR methods).
(B) Bar graph showing the ratio of 22-mer to 26G-
RNA in each strain using the data in (A).
(C) Bar graph comparing the levels of p- and ppp-
26G-RNA cloned from WT (avr3x) or pir-1(C150S)
worms. Small RNAs were directly ligated to clone
p-26G-RNAs (yellow) or pretreated with recombi-
nant PIR-1 to remove b and g phosphates before
ligation to clone p- and ppp-26G-RNAs (cyan).
Reads were normalized to total 21U-RNAs.
(D) Bar graph showing the ratio of ppp-26G-RNA to
p-26G-RNA in WT and pir-1(C150S) data from (C).
(E) Model of 26G-RNA biogenesis.
p values were obtained using an unpaired Stu-
dent’s t test (one-tailed for A, B, and D and two-
tailed for C) based on two replicas of each sample;
error bars represent one standard error. See also
Figure S6.
ll
Articlethe loss of phasing at distances greater than 40 nt, and other mi-
nor details (Figures S5B–S5D). More details and findings of this
simulation analysis are provided in Figures S6A and S6B.
pir-1 mutants exhibit defects in 26G-RNA maturation
Ametagene analysis based solely on the pir-1mutant data proved
impractical, as the depletion of 26G-RNAs made the signal very
weak (Figure S6C). Instead, we mapped sense and antisense
RNAs cloned from the pir-1 mutants to the metagene intervals
defined by the WT data. Both 26G-RNAs and complementary
sense-stranded22-merRNAs (positioned at23 in themetagene)
were dramatically reduced in pir-1 mutants (Figure 6A). Interest-
ingly, 26G-RNAs were disproportionately reduced compared to
the sense-stranded 22-mer RNAs (Figure 6B). The ratio of 26G-
RNAs to 23 22-mer-RNAs was 31:1 for WT animals, 3:1 for the
pir-1 null mutant, and 11:1 for the pir-1(C150S). Phased 26G-
RNAswere not detected. These finding suggest that PIR-1 activity
is required both for the processivity of the Dicer-ERI complex and
for the maturation of antisense 26G-RNAs.MolecuSince PIR-1 is an RNA phosphatase,
one possible explanation for the above
finding is that dephosphorylation of the
26G-RNAprecursors promotematuration.
If so, we reasoned that unprocessed ppp-
26G-RNAs should increase relative to p-
26G-RNAs in pir-1 mutants and that this
difference might be enhanced by binding
and protection of the unprocessed ppp-
RNA by catalytically dead PIR-1(C150S),
as predicted by our in vitro studies above.
To explore this possibility, we generatedsmall RNA sequencing libraries using a ligation-dependent
method that requires a 50 monophosphate for efficient cloning
(Gu et al., 2011; Li et al., 2020). For each mutant and WT sample,
we prepared libraries with or without pretreating the RNA with re-
combinant PIR-1. As expected, most 26G-RNAs in WT worms
(94%) were recovered without PIR-1 digestion when normalized
to those with recombinant PIR-1 treatment, suggesting that these
26G-RNAs bear 50 monophosphate. In contrast, we found that
~40% of 26G-RNAs present in the pir-1 mutants were resistant
to ligation-dependent cloning unless treated with recombinant
PIR-1, suggesting that they contain a 50 triphosphate group (Fig-
ures 6C and 6D). Taken together, these findings suggest that
PIR-1 dephosphorylates 26G-RNA precursors and is required
for efficient 26G-RNA maturation by the Dicer-ERI complex.
DISCUSSION
Eukaryotic cells can sense and modify structural features of
RNAs to regulate their stability and functions and distinguishlar Cell 81, 546–557, February 4, 2021 553
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Articleself- from viral-RNAs. For example, the Dicer protein binds
dsRNAs and processes them into duplexed siRNAs andmiRNAs
that engage Argonaute proteins to mediate sequence-specific
viral immunity and mRNA regulation. Conversely, the human
RIG-I protein, which contains a Dicer-related helicase domain,
detects duplex ppp-RNAs produced by viral RdRPs and then ini-
tiates a non-sequence-specific cascade of secondary signals
that promote viral immunity (Hornung et al., 2006; Kato et al.,
2006). Here, we have shown that the Dicer-interacting protein
PIR-1, like its human and insect virus homologs, removes the b
and g phosphates from ppp-RNAs in vitro, generating 50 p-
RNAs. In vivo, PIR-1 is required for fertility and for the accumula-
tion of 26G-RNAs antisense to hundreds of spermatogen-
esis mRNAs.
26G-RNAs are an enigmatic species of Dicer product best un-
derstood for their role in spermatogenesis, where alongwith their
AGO-related Argonaute co-factors ALG-3/4, they promote sper-
matogenesis-specific gene regulation and epigenetic inheri-
tance (Conine et al., 2010, 2013; Han et al., 2009). During embry-
onic development, 26G-RNAs engage the Argonaute ERGO-1 to
regulate a group of repetitive RNAs of unknown functions (Gent
et al., 2010; Vasale et al., 2010). Mutations that inactivate the
ERGO-1 pathway cause enhanced RNAi (ERI phenotypes; Ken-
nedy et al., 2004; Simmer et al., 2002). While our genetic studies
only revealed a role for PIR-1 in the larval-stage ALG-3/4 26G-
RNA pathway, it is likely, as previously shown for other RNAi
components, including Dicer and RDE-1 (Parrish and Fire,
2001; Tabara et al., 1999, 2002), that the embryonic functions
of PIR-1, including its possible function in the ERI pathway, are
rescued in embryos of heterozygous mothers by maternally pro-
vided PIR-1(+) activity.
A model for 26G-RNA biogenesis
Our findings are consistent with the idea originally proposed by
Blumenfeld and Jose (2016) that 26G-RNAs are produced in a
phasedmanner alongmRNAs through successive cycles of anti-
sense transcription by RRF-3 and cleavage by Dicer. Our find-
ings allow us to add details to this model for phased biogenesis
of 26G-RNAs and propose where PIR-1 functions in this process
(Figure 6E). After transcription by RRF3, at least 23 nt are
removed from the 30 end of the template RNA. Then, before Dicer
cleaves, a 30-to-50 exonuclease (possibly ERI-1b) digests the
template RNA, removing the transcription start site C residue
(1 in the model; Figure 6E) to generate a dsRNA with a 1-nt re-
cessed 30 end. Binding of the recessed 30 end and engagement
of the Dicer helicase domain positions Dicer to process the
duplex into a 22-mer-RNA passenger strand (by cleavage at
23 relative to the initiator C residue) and a 26G-RNA strand
with a 3-nt 30 overhang (Figure 6E; see also Welker et al.,
2011). The cycle is repeated when RRF-3 reinitiates transcription
at the C residue closest to the processed 30 end of the template.
Our analysis failed to uncover evidence for processive dicing of
longer RdRP-derived dsRNA substrates. We cannot, however,
rule out the possibility that longer substrates are generated
and diced processively at much lower frequencies.
PIR-1 could remove the diphosphate from ppp-26G-RNA
before or after dicing (Figure 6E). Indeed, in vitro studies suggest
that Dicer is not sensitive to the phosphorylation status of the554 Molecular Cell 81, 546–557, February 4, 2021substrate 50 end (Welker et al., 2011; Zhang et al., 2002). More-
over, the levels of sense-stranded 22-mer RNA fragments (pre-
sumptive Dicer products) and ppp-26G-RNAs were increased
in pir-1mutants compared toWTworms. Thus, dicing still occurs
in pir-1mutants, but maturation into p-26G-RNAs appears to be
reduced. Perhaps diphosphate removal is required for efficient
transfer of diced 26G-RNA products to the Argonautes ALG-3/
4, whose homologs prefer monophosphorylated guide RNAs.
PIR-1 exhibits ppp-RNA-specific binding activity
In vitro studies on PIR-1 revealed a surprising activity associated
with the presumptive catalytically dead C150S lesion. This muta-
tion behaved like a strong loss-of-function allele, causing small-
RNA and developmental defects identical to those caused by a
pir-1 null mutation. However, we found that PIR-1(C150S) never-
theless bound specifically to ppp-RNAs in our gel-shift assays.
Structural studies on members of the cysteine phosphatase su-
perfamily to which PIR-1 belongs have shown that during catal-
ysis, the cysteine motif generates a covalent cysteinyl-S-phos-
phate intermediate that is later hydrolyzed in a two-step
reaction (Sankhala et al., 2014; Takagi et al., 1998). The substitu-
tion of serine for cysteine in PIR-1 C150S replaces the reactive
sulfhydryl group of cysteine with a hydroxyl group, preventing
formation of the covalent linkage. The finding that this catalyti-
cally dead protein retains its ppp-RNA-specific binding activity
suggests that substrate recognition is separable from catalysis
in PIR-1. Thus, it is possible that PIR-1 utilizes its affinity for
ppp-RNAs to recognize RRF-3 products and help recruit Dicer
and other ERI complex co-factors to the nascent duplex.
It is interesting to note that a baculovirus-encoded PIR-1 ho-
molog, PTP, functions as a virulence factor that promotes a
fascinating behavioral change in infected host caterpillars (Kat-
suma et al., 2012). Ingested virus spreads to the brain, and the
infection eventually causes the caterpillar to migrate to upper fo-
liage, where the dying animal ‘‘liquifies’’—a process thought to
maximize dispersal of the virus. Interestingly, ptp null mutants
were partially defective in brain infectivity and behavioral modifi-
cation, but PTP C119S mutants supported both activities, sug-
gesting that PTP provides a purely structural capacity to pro-
mote virulence (e.g., through its interaction with viral capsid
protein) (Katsuma et al., 2012). However, if PTP C119S selec-
tively binds ppp-RNA (similar to PIR-1 C150S), then it remains
possible that PTP C119S interacts with and promotes viral pack-
aging of cellular or viral ppp-RNAs that function as small-RNA
cues that alter host behavior. This possibility is particularly
intriguing, as a growing number of reports have described the
modulation of neural and behavioral activity by small RNAs orig-
inating in other tissues (Bharadwaj and Hall, 2017; Cai et al.,
2018; Hou et al., 2019; Posner et al., 2019).
PIR-1 is required for robust levels of CSR-1 22G-RNAs
We were surprised to find that pir-1mutants exhibit significantly
reduced levels of all CSR-1 22G-RNAs. The biogenesis of 22G-
RNAs does not require Dicer. Instead, 22G-RNAs appear to be
produced directly by the RdRP EGO-1 and are then loaded,
without further processing, as ppp-RNAs onto their downstream
Argonaute co-factors. It is therefore intriguing that levels of CSR-
1 22G-RNA, but not WAGO 22G-RNA, were depleted in pir-1
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Articlemutants. The upstream events in the WAGO 22G-RNA pathway
differ from events involved in the CSR-1 pathway. For example,
WAGO 22G-RNA biogenesis is initiated by RDE-1 guided by an
siRNA processed by Dicer or Piwi Argonaute (PRG-1) guided
by a piRNA. When RDE-1 and PRG-1 bind target mRNAs, they
recruit cellular RdRPs that synthesize WAGO 22G-RNAs
(Ashe et al., 2012; Bagijn et al., 2012; Grentzinger et al., 2012;
Lee et al., 2012; Pak and Fire, 2007; Shen et al., 2018; Shirayama
et al., 2012; Yigit et al., 2006; Zhang et al., 2018). Whether an up-
stream Argonaute functions in the CSR-1 pathway is unknown.
Although 26G-RNAs have not been detected formost CSR-1 tar-
gets, perhaps they are short lived, developmentally restricted
(e.g., to larvae), or are simply very low abundance and have
beenmissed. Further investigation will be required to understand
this connection between PIR-1 and CSR-1.
Limitations of study
Here, we have shown that PIR-1 is an RNA phosphatase and that
null and catalytic alleles exhibit delayed development, larval ar-
rest, and reduced levels of small RNAs in two Argonaute path-
ways, the ALG-3/4 pathway and the CSR-1 pathway. A striking
feature of the PIR-1mutant phenotype is the dramatically slowed
development of homozygous larvae. Those pir-1 homozygotes
that do reach adulthood take nearly twice as long as WT animals
to do so, while their developmentally retarded siblings behave
like otherwise active and healthy larvae for the course of an
approximately WT lifespan of 16–18 days. The developmental
delay of pir-1 limits our ability to compare its patterns of RNA
and protein expression to that of WT animals. We must either
use chronologically matched or developmentally matched pop-
ulations, and some developmental stages, such as embryos, are
entirely absent due to infertility. Previous studies have shown
that the loss of ALG-3/4 and CSR-1 pathways cause defects in
male and female fertility, respectively. However, mutants that
perturb these Argonaute pathways do not exhibit delayed devel-
opment (Claycomb et al., 2009; Conine et al., 2010; Gent et al.,
2009; Han et al., 2009; Vasale et al., 2010). Moreover, the pir-1
sterile phenotype is more severe than that of alg-3/4 or csr-1mu-
tants. For example, alg-3/4 and csr-1males are partially fertile at
the permissive temperature of 20C (Conine et al., 2013), but pir-
1 males are unconditionally sterile. csr-1 hermaphrodites make
some embryos, but most pir-1 adult hermaphrodites do not
even make oocytes. Unlike the ALG-3/4 and CSR-1 Argonautes,
PIR-1 is expressed throughout the worm, and thus, PIR-1 may
have functions outside the germline that are required for both
developmental progression and fertility. Thus, we do not know
why pir-1mutants exhibit arrested development, and this defect
is unlikely to stem from its role in regulating germline Argonautes.
Perhaps the presence of cellular RdRPs in C. elegans makes
RNA phosphatase activity essential in order to ensure that accu-
mulating ppp-RNA products do not compromise RNA homeo-
stasis or activate heretofore unknown innate immunity mecha-
nisms. Conceivably, the absence of PIR-1 activity could trigger
a diapause that is normally triggered only when an excessive
cytoplasmic accumulation of viral ppp-RNAs overwhelms the
capacity of PIR-1 and Dicer-mediated immunity. A diapause in
response to ppp-RNA might allow animals to postpone repro-
duction until after the viral infection is cleared. Understandingthe essential role of PIR-1 in development and its possible func-
tion in antiviral immunity will require further investigation beyond
the scope of this paper.
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Mendeley Data: https://dx.doi.org/10.17632/g3z3k2fppy.1.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
C. elegans Strains and Genetics
The C. elegans Bristol N2 strain and its derivatives used in this study were cultured essentially as described (Brenner, 1974). NGM
plates containing 10-25 mg/L ivermectin were used to select for pir-1 homozygous worms. Worms strains used in this study are listed
in Table S2.
METHOD DETAILS
Cloning, Expression, and Purification of Recombinant PIR-1
Wild-type (WT) or mutant PIR-1 cDNA sequences lacking the first ATG was inserted between the NdeI site and BamHI sites of
pET-28a (Novagen) in fusion with the 6 3 Histidine tag N-terminally. The resulting plasmid was transformed into BL21 (DE3) RIL
E. coli cells, which were grown in 1 l of LB medium at 37C to an OD600 of 0.4, and induced for 4 hr with 1 mM IPTG at room tem-
perature. Cells were pelleted at 5,000x g for 10 min at 4C and lysed by sonication in 25 mL of lysis/binding buffer (50 mM Tris-
HCl pH 7.5, 700 mM NaCl, 5 mM b-mercaptoethanol, 5% glycerol, 15 mM imidazole, 0.01% NP-40). S100 fractions were prepared
by ultracentrifugation at 100,0003 g at 4C for 1 hr. In a 15mL conical tube, 2 mL of HisPur beads (Thermo Scientific) were washed 3
times with the lysis/binding buffer and centrifuged at 3,0003 g between washes. The beads were mixed with the S100 supernatant,
transferred to a 50mL conical tube for rotation at 4C for 1 hr. Beadswere transferred to an empty Poly-Prep chromatography column
(Bio-Rad) and washed at 4C with at least 200 bead volumes of the lysis/binding buffer. Elution was performed at 4C with 500 ml of
imidazole buffer per fraction (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM b-mercaptoethanol, 5% glycerol, 400 mM imidazole,
0.01%NP-40). Peak fractions were analyzed by 10%SDS-PAGE followed by Coomassie Blue staining. Proteins were dialyzed using
50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 50% glycerol, 0.01% Triton X-100.
PIR-1 Activity Assays
To examine the dephosphorylation activity of recombinant PIR-1, a 26-nt long ppp-RNA1 (ppp-GGAUCCUUGAAAUGGAACAUCU-
GAAU) and a 103-nt long ppp-RNA2 (GUUGUAGUGUUCCCGCUCCAUGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUA-
GUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUUUU) were transcribed in vitrowith T7RNApolymerase followed
by gel-purification using 15% PAGE/6M urea (two bands were co-purified for both RNA1 and RNA2). In Figures 1B (RNA1) and S1B
(RNA2), 1 mMof ppp-RNAwas co-digested with ~0.25 mMof recombinant WT or mutant PIR-1 and 0.25 U of Terminator exonuclease
(Epicenter) in 10 ml 1X PIR-1 reaction buffer containing 50 mM Tris-HCl (pH 8.0) and 0.1 MNaCl, 2 mMDTT, and 2mMMgCl2 at 30
C
for 1 hr. The reaction was stopped by adding formamide gel loading buffer II (Ambion), and run on a 15% PAGE/6 M urea with 0.5X
TBE buffer. The RNA was visualized with UV light after staining with SYBR Gold (Thermo Fisher Scientific).
The above in vitro transcription predominantly generates byproduct RNAs of much bigger size likely due to template switching when
T7 RNA polymerase runs off a template. This prompted us to generate a precursor RNA ppp-GUCAUUCAG AUGUUCCAUUUCAAG-
GAGGGUCGGCAUGGCAUCUCCACCUCCUCGCGGUCCGA CCUGGGCUACUUCGGUAGGCUAAGGGAGAAG, which contains a
Hepatitis delta virus (HDV) ribozyme (underlined) to self-cleave the precursor, generating ppp-RNA3 co-transcriptionally (ppp-GU-
CAUUCAGAUGUUCCAUUUCAAGGA; Sch€urer et al., 2002). In Figure 1C, ppp-RNA3 alone, ppp-dsRNA generated using ppp-RNA3
annealed with an RNA oligo 50OH-UUGAAAUGGAACAUCUGAAUGAC (the oligo is smaller than ppp-RNA3 and thus can be separated
fromppp-RNA3 in gel purification) and ppp-RNA/DNAhybrid generated using ppp-RNA3 annealedwith a DNA oligo 50OH-TTGAAATG-
GAAC ATCTGAATGAC in 1X PIR-1 reaction buffer (the annealing rate is close to 100% as shown in Figure S1C), digested with recom-
binant PIR-1 using the above reaction condition, and gel-purified to obtain processed ppp-RNA3. Then these processed RNAs were
subjected to digestion with 0.05 U of Terminator in a 10 ml PIR-1 reaction buffer at 30C for 30 minutes, resolved on a 15% PAGE/
6M urea, and visualized using SYBR Gold staining.
In the binding assay, recombinant PIR-1 (no Terminator) was incubated with ppp-RNA1 (Figures 1D and 1E) or double stranded
nucleic acids including ppp-RNA3/RNA oligo or ppp-RNA3/DNA oligo (Figures S1D and S1E) using 1X PIR-1 reaction buffer at
20C for 40 minutes. The reaction was resolved using a 10% native PAGE gel containing 50 mM Tris-HCl (pH 8.0; Figure S1D) or
25 mM Tris and 192 mM Glycine (pH 8.3; Figure S1E) at room temperature and visualized using SYBR Gold staining.
Worm Transgenics
GFP- and FLAG-tagged pir-1 strains were generated by microparticle bombardment (Praitis et al., 2001) or Mos1-mediated single-
copy insertion (Frøkjaer-Jensen et al., 2008). Transformants were identified using an unc-119 transformation rescue strategy.
Integrated lines were crossed with pir-1(tm3198)/mnC1* males, and hermaphrodite progeny not carrying the mnC1 balancer chro-
mosome (which wasmarked with a nuclear Psur-5::GFP transgene) were allowed to self-fertilize. Several F2 were allowed to produce
offspring and then analyzed by PCR to worms positive for the transgene but homozygous for the pir-1 deletion allele.Molecular Cell 81, 546–557.e1–e5, February 4, 2021 e2
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The pir-1(C150S) mutant was generated by injecting a pre-assembled Cas9 ribonucleoprotein complex and oligos to template ho-
mology directed repair, essentially as described (Paix et al., 2015), but injections included rol-6 (su1006) as an injection marker.
Genome editing events were identified among the F1 rollers.
Immunoprecipitation and Western Blot Analyses
Immunoprecipitation and western blots were performed as described previously (Gu et al., 2009).
MudPIT Analysis
1. Identification of PIR-1 binding partners (Tables 1 and S1)
Proteins were precipitated in 23% trichloroacetic acid final concentration and rinsed with cold acetone. Air-dried pellets were dis-
solved in 60 ul of 8 M urea 100 mM Tris pH 8.5 and reduced with TCEP (5 mM final concentration) for 20 min, followed by alkylation
by iodoacetamide (10mMfinal concentration) for 15min. Sample is diluted to 2M urea 100mMTris pH 8.5. Calcium chloride to 1mM
final concentration and 1 ug of trypsin (Promega, product V5111) is added. The sample is placed in a 37C shaker for 18 hr. Formic
acid to 5% is added and the sample is centrifuged at 16000 rcf. for 15 min. The supernatant is transferred to a new tube for loading
onto the MudPit column.
2. Mass spectrometry analysis by MudPIT (Tables 1 and S1, bottom; Wolters et al., 2001)
Digested protein was pressure loaded onto an in-house biphasic microcapillary column (250 mm id/360 mm od capillary of 30 cm
length) packed with a strong cation exchanger (SCX Luna, Phenomenex, Torrance, CA, USA) and RP resin (Aqua C18, Phenomenex,
Ventura, CA, USA). Subsequently, an analytical microcapillary column packed with RP resin was attached to the biphasic column in
line with an Eksignet HPLC on an LTQOrbitrap (Thermo Fisher Scientific, San Jose, CA, USA). Samples were analyzed using a 3 step
separation with the first step corresponding to a desalting and transfer step. The second step used a 30% pulse of 500 mM ammo-
nium acetate for 5 min followed by a 155 min gradient to 79% ACN. The third step had a 100% 500 mM ammonium acetate pulse.
Peptides eluted from the microcapillary column (100 mm id/360 mmod capillary of 12 cm length) were electrosprayed directly into the
mass spectrometer with the application of distal 2.5 kV spray voltage at an inlet capillary temperature of 200C. From one full-scan of
mass spectrum (400–1800m/z), 5 most intense ions were sequentially isolated and fragmented by CIDwith 35% normalized collision
energy repeating continuously through each step of the multidimensional separation. The m/z ratios selected for MS/MS were
dynamically excluded for 120 s.
3. Mass spectrometry (Table S1, top)
Digested protein was pressure loaded onto an in-house biphasic microcapillary column (250 mm id/360 mm od capillary of 30 cm
length) packed with a strong cation exchanger (SCX Luna, Phenomenex, Torrance, CA, USA) and RP resin (Aqua C18, Phenomenex,
Ventura, CA, USA). Subsequently, an analytical microcapillary column packed with RP resin was attached to the biphasic column in
line with an Agilent 1100 quaternery pump coupled to an LTQ (Thermo Fisher Scientific, San Jose, CA, USA). Samples were analyzed
using a 7 step separation with the first step corresponding to a desalting and transfer step. Steps 2-7, used 500 mM ammonium ac-
etate pulses of 20%,.30%, 40%, 70%, 100% and 100%, respectively. Peptides eluted from the microcapillary column (100 mm id/
360 mm od capillary of 12 cm length) were electrosprayed directly into the mass spectrometer with the application of distal 2.5 kV
spray voltage at an inlet capillary temperature of 200C. From one full-scan of mass spectrum (300–2000 m/z), 8 most intense
ions were sequentially isolated and fragmented by CID with 35% normalized collision energy repeating continuously through
each step of the multidimensional separation. The m/z ratios selected for MS/MS were dynamically excluded for 60 s.
4. Mass spectrometry data processing
All mass spectra were converted to ms2 files by RawConverter (Version 1.1.0.23; (He et al., 2015), with monoisotopic peak selection
for Orbitrap files. All files were searched against the protein database from https://www.wormbase.org/ (WS266), with common con-
taminants and reversed decoy sequences added (Peng et al., 2003). The searches were done with ProLuCID, version 1.4 (Xu
et al., 2015).
For Orbitrap data shown in Table 1 and Table S1, bottom, the search parameters were; unlimited missed cleavages, precursor ion
tolerance 0.3 Da, fragment mass tolerance 600 pm, no variable modification, half or fully tryptic, and fixed cysteine modification of
57.02146. A ‘‘heavy’’ search with the same parameters with 100% 15N incorporation was done also. The LTQ data in Table S1-Top,
was searchedwith; unlimitedmissed cleavages, precursor ion tolerance 50 ppm, fragmentmass tolerance 600 pm, no variablemodi-
fication, half or fully tryptic, and fixed cysteine modification of 57.02146.
Search results were filtered with DTASelect version v2.1.12 (Tabb et al., 2002). For Orbitrap data- -p 2 -y 1–trypstat–pfp 0.01–ex-
tra–pI -DM 5–DB–dm -in -t 1–brief –quiet. For LTQ data- -p 2 -y 1–trypstat–pfp 0.01–extra–pI–DB–dm -in -t 1–brief –quiet.
Preparation of Tissues for Microscopy
To visualize live animals, washed worms were mounted on slides with a 2% agarose pad with M9 buffer containing 0.4% levamisole
to paralyze the animals.
Tissues were prepared for DAPI staining and immunofluorescence were carried out as described in Claycomb et al. (2009). For
gonad dissection 40 to 50 L4 to young adult worms were picked from plates and washed extensively with 1 3 Egg Buffer (25 mM
HEPES-NaOH, pH 7.4, 118 mM NaCl, 2 mM EDTA, 0.5 mM EGTA, 0.1% Tween-20) to eliminate bacteria. The buffer was replacede3 Molecular Cell 81, 546–557.e1–e5, February 4, 2021
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of a fine hypodermic needle at either the head below the pharynx or at the tail to release the gonads (and intestines). An equal volume
of fixative solution (3.7% formaldehyde in 13 Egg Buffer without Tween-20) was added and pipetted up and down to further extrude
and dissociate germline tissue from the rest of the animals. Fixation was allowed to occur for 5min at room temperature. All but about
10 ml of solution were removed from the coverslip. The coverslip was picked up by touching the drop at the center of a positively
charged slide (VWRVistaVision HistoBond), with one corner of the coverslip slightly protruding from the edge of the slide. To promote
adherence of the tissues to the slide, excess fixative was removed from the edge of the coverslip using torn strips of absorbent filter
paper. The tissue was freeze-cracked by placing the slide on a pre-cooled aluminum block on dry-ice for at least 10 min and quickly
flicking the protruding corner of the coverslip, removing it from the slide. The slidewas immediately dipped in cold (–20C)methanol in
a Coplin jar for 1 min, and then transferred to 13 PBS buffer (10 mM phosphate, pH 7.4, 137mMNaCl, 2.7 mMKCl) containing 0.1%
Tween-20 (PBST) at room temperature.
For DAPI staining only, slides were washed in PBST for 10min, PBST containing 0.5 mg/ml DAPI for 10min, and PBST for 30min, at
room temperature. Excess buffer was removed from the slides without letting the sample dry completely, and slides were mounted
with 10 ml of Vectashield mounting medium placed at the center of a 223 22-mm coverslip. Excess medium was removed by invert-
ing and pressing the mounted slide on a paper towel, and the edges were sealed with transparent nail polish.
For immunofluorescence staining of PIR-1::GFP, slides were immersed in (–20C) methanol for 1 min, then washed three times in
PBST, 10min each. Slides were blocked by adding 100 ml 0.5%BSA in PBST onto the worms, covering with a square Parafilm cover-
slip, and incubating in a humid chamber at room temperature for at least 30 min. The slides were dipped in PBST to remove the Par-
afilm. Mouse monoclonal anti-GFP antibody (Wako) was diluted 1:100 in blocking solution and 100 ml was placed on the sample and
covered with a Parafilm coverslip, and slides were incubated in a humid chamber for 2 hr at room temperature or overnight at 4C.
After three 10-min washes in PBST at room temperature, slides were incubated for 2 hr at room temperature with a 1:500 dilution of
FITC-conjugated donkey anti-mouse (Jackson), and then washed, stained DAPI, and mounted as described above.
Images of live or fixed samples were acquired with a Zeiss Axioplan 2 microscope using Zeiss AxioVision software.
Small RNA extraction, cloning, and sequencing
RNA was extracted from worms or from Argonaute immunoprecipitates with TRI Reagent (MRC, Inc.), according to the manufac-
turer’s protocol. Small RNA libraries were prepared essentially as described (Gu et al., 2011; Li et al., 2020). Briefly, ~1 mg of total
RNA was used for cloning small RNAs either via the conventional ligation-based method or the one-pot cloning method; Tobacco
Acid Pyrophosphatase (Epicenter, discontinued) or recombinant PIR-1 was used to dephosphorylate ppp-RNAs for cloning ppp-
RNAs when needed while no such treatment was required for cloning p-RNAs. Libraries were sequenced using Illumina NextSeq,
HiSeq 4000, and Genome Analyzer II at UMass Medical School and UC Riverside.
QUANTIFICATION AND STATISTICAL ANALYSIS
High-throughput sequencing readswere processed andmapped toC. elegans genome and annotations (WormBase releaseWS215)
using Bowtie 0.12.7 (Langmead et al., 2009) and further analyzed using customPERL scripts, which have been deposited inGitHub at
https://github.com/guweifengucr/WGlab_small_RNA_analysis for free access (Dai and Gu, 2020; Gu et al., 2009; Li et al., 2020). The
Generic GenomeBrowser was used to visualize the alignments (Stein et al., 2002). All the statistics in Figures 4C, 4D, 6A–6D, and S4E
were obtained using unpaired Student’s t test provided in LibreOffice 6.1 Calc based on two replicas of each sample; we used F-test
from LibreOffice 6.1 Calc to determine if the data follows Student’s t test with equal variance or unequal variance. The bar height
(Figures 4C, 4D, 6A–6D, and S4E) and the line (y axis, Figures S4A–S4D) represents the mean; in all the above figures, one standard
error of mean (SEM) was indicated; ‘n’ represents the gene number in the indicated group for counting the total reads. All the above
information as well as the normalization standard was provided in the figure legends.
The metagene analysis obtained the distribution of small RNAs (represented by their 50 nt positions) of various sizes flanking 26G-
RNAs (also represented by their 50 nt positions, i.e., the 1 template C’s). It first obtained the small RNA profile flanking each 26G-
RNA and then the accumulative profile using all 26G-RNAs, as shown in Figures 5A, 5B, and S5A. The custom PERL scripts for these
analyses were deposited in GitHub, as shown above.
A simulation algorithm was developed to verify the metagene results using the simulated small RNA data and parameters obtained
from the experimental data. In each round of simulation, one thousand of RNA molecules, each with a 1000-nt random sequence
containing 21%C (frequency in templatemRNAs), are generated; 20 C’s are randomly selected as1 C’s and used to generate initial
26G-RNAs; if the24 (23 nts upstream of1) is C, a phased 26G-RNA is generated; otherwise, the next available upstream template
C is selected; the next round of phased 26G-RNAs starting at47 regions are generated using the same rule and so on (Figure S5B).
The selected C’s for both the initial 26G-RNAs and phased 26G-RNAs in the ALG-3/4 pathway are limited to the 50 and 30 10% of
mRNAs since most ALG-3/4-bound 26G-RNAs are located there (Conine et al., 2010). To achieve the best result, each C could
fail to generate a 26G-RNA at 30%–40% rate, and if a failure occurs, next upstream C can serve as a template nt also with a
30%–40% failure rate. This failure rate, the only parameter not obtained from the experimental data, simply mimics RNA degradation
or other competing processes, and was empirically determined based on the best fitting results. To minimize variations, the averageMolecular Cell 81, 546–557.e1–e5, February 4, 2021 e4
ll
Articleresults of 100 rounds of simulations were obtained, as shown in Figures S5C and S5D. The control utilizes the same parameters and
algorithm but only allows for generating initial 26G-RNAs (no recursive mode).
To examine if phased 26G-RNAsmay be caused by a higher frequency of nt C in the24 template region, the frequencies of nt C’s
flanking any specified C’s (designated as 1) on template mRNAs were examined (Figures S6A and S6B). This is basically a meta-
gene motif analysis, since each genomic C locus has a weight 1 instead of the read numbers in the metagene analysis (Figures 5 and
S5). We also included a motif analysis only using template C’s which generate 26G-RNAs in the experimental data (Figures S6A and
S6B). If a 26G-RNA locus is selected, it could represent a phased 26G-RNA, meaning there is an initial 26G-RNA locus at the 23 po-
sition and therefore the 23 position enriches C nts. By contrast, the 24 position won’t enrich C nts since for any given 1 C the
biogenesis of phased 26G-RNAs at 24 just follows the genomic C frequency, i.e., 21%. As expected, this motif analysis exhibits
a sub-peak at the 23 position and no obvious sub-peak at 24 (Figures S6A and S6B).e5 Molecular Cell 81, 546–557.e1–e5, February 4, 2021
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SUPPLEMENTARY FIGURE LEGEND 
Figure S1. PIR-1 binds and modifies ppp-RNAs. Related to Figure 1.  
A) The cleared lysates, flow-throughs and elution fractions obtained from a recombinant His6-
tagged PIR-1 purification were resolved on a 12% denaturing protein PAGE gel and visualized 
with Coomassie Blue staining. 
B) Single-stranded ~100 nts long ppp-RNAs in vitro transcribed were co-treated with PIR-1 and 
Terminator or with control conditions and resolved on a 15% PAGE/6M urea. 
C)  Single-stranded ppp-RNAs were annealed with a complementary RNA or DNA oligo, and 
resolved on a 15% native PAGE gel to check the annealing efficiency. 
D) WT and C150S PIR-1 were incubated with double-stranded nucleic acids including ppp-
RNA/RNA oligo or ppp-RNA/DNA oligo, and then resolved on a native 12% PAGE gel using a 
buffer containing 50 mM Tris (pH 8.0). 
E) WT and C150S PIR-1 were incubated with single-stranded ppp-RNAs and then resolved on a 
native 12% PAGE gel using a buffer containing 25 mM Tris and 192 mM Glycine (pH 8.3). 
 
Figure S2. Analysis of PIR-1 isoforms and interacting proteins. Related to Table 1, Table 
S1 and Figure 2. 
A) Western blot analyses of PIR-1 IP from pir-1::3xflag-rescued young adult worms identified 
PIR-1-interacting proteins including DCR-1, RRF-3, DRH-3 and ERI-1b. 
B-D) Western blot analyses of PIR-1 IPs from WT (avr3x) and single-copy pir-1::gfp-rescued 
young adults in dcr-1, eri-1, drh-3, and rde-4 mutant backgrounds. Tubulin was used as a 
control. 
E) Western blot analyses of DRH-3 IP using N2 and pir-1::3xflag-rescued young adult worms 
identified PIR-1 and DCR-1.  





Figure S3. Characterization of pir-1 loss-of-function phenotypes and expression patterns. 
Related to Figure 3. 
A) Live rescued pir-1 mutant larvae with an integrated pir-1::gfp transgene which was 
introduced using bombardment, reveal a nearly ubiquitous protein expression pattern. 
B) Images of live non-integrated bombardment lines exhibit high PIR-1::GFP expression in only 
a few somatic cells with both nuclear and cytoplasmic localization. 
C) Quantification of visible phenotypes exhibited by 133 tm3198 homozygotes grown for seven 
days at 20 oC. 
D) Images of live pir-1 mutant animals exhibiting major phenotypes scored in C). 
 
Figure S4. Analysis of small RNAs in pir-1 C150S mutants. Related to Figure 4.  
 A-D) distribution of small RNAs along mRNA templates: each mRNA is evenly divided into 50 
intervals from 5' to 3' ('X' axis); 22 or 26G-RNAs are assigned to each interval after 
normalization to total 21U-RNAs; a cumulative number is first obtained for each interval using all 
mRNAs and divided by the total mRNA number to obtain the average ('Y' axis) in WT 
(avr3x,blue) and pir-1 mutant (red). The dotted line represents one standard error based on two 
replicas of samples. 
E) 26G-RNAs and/or 22G-RNAs derived from the 'n' number of genes in each small RNA 
pathway in WT (avr3x) or pir-1 catalytic mutant were compared after normalization to total 21U-
RNAs. An enlarged figure was shown for the ALG-3/4 26G-RNA comparison. The two-tailed P 
values were calculated for two replicas using unpaired student's t-test.  
 
Figure S5. Metagene analysis of small RNAs around 26G-RNAs. Related to Figure 5.  
A) distribution of small RNAs in the ALG-3/4 pathway in L4-stage hermaphrodites: each 26G-
RNA is represented by its very 5' G, defined as -1 using a template mRNA C nt; small RNA 




(40 nts downstream of -1) region ('X' axis) are obtained for each 26G-RNA after normalization to 
total 21U-RNA reads, and accumulated for all 26G-RNAs. Top panel represents sense RNAs 
derived from mRNAs and bottom represents antisense RNAs made by RdRPs. 
B) A mathematical simulation scheme for modeling the distribution of 26G-RNAs with all 
parameters based on the experimental data but a 40% failure rate of each template C usage 
empirically determined for obtaining the best fit. 
C-D) distribution of 26G-RNA reads around specified 26G-RNA loci (-1) in the ALG-3/4 and 
ERGO-1 pathways based on the experimental and simulation data using the same method as in 
A); 'Y' axis represents the ratio of the 26G-RNA reads at each position to those at mRNA -1; the 
simulation control uses the same parameters but does not allow for generating phased 26G-
RNAs. 
 
Figure S6. Metagene analysis of 26G-RNA distribution. Related to Figure 6.  
A-B) Analysis of C nt distribution around -1 C on template RNAs. All the -1 C encoding the first 
nt of 26G-RNAs in the ALG-3/4 (A) and ERGO-1 (B) pathways are selected from the 
experimental (blue) and simulation data (red and black), and as a genome sequence control, all 
C's on template mRNAs are selected (green). The positions of these C's are defined as -1, and 
the nt C frequency at each upstream (-1 to -30) and downstream (1 to 30) position was obtained 
using the selected loci. Unlike those metagene analyses in Figure 5 and S5, each C locus bears 
a weight of 1 instead of the RNA read number. The simulation data and control are the same as 
those used in Figure S5. Dotted lines represent one-standard-error bars in the experimental 
data, and those bars in the simulation data are too small to draw. On the left part of the figures, 
the black lines are hidden underneath the red lines. 
C) distribution of small RNAs in the ALG-3/4 pathway in pir-1 tm3198 mutants: each 26G-RNA 
is represented by its very 5' G, defined as -1 using a template mRNA C nt; small RNA reads ('Y' 




downstream of -1) region ('X' axis) are obtained for each 26G-RNA after normalization to total 
21U-RNA reads, and accumulated for all 26G-RNAs. Top panel represents sense RNAs derived 
from mRNAs and bottom represents antisense RNAs made by RdRPs. 
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Figure S2. Analysis of PIR-1 isoforms and interacting proteins. Related to Table 1, Table
S1 and Figure 2.



























after 7 days at 20ºC (n=133)
Normal to mild protruding vulva  45%
Severe protruding vulva   19%
Smaller without vulva (L3/L4-like) 21%
Sick/dead that burst   15%
malformed oocytes
Figure S3. Characterization of pir-1 loss-of-function phenotypes and expression patterns.
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Table S1. PIR-1-interacting proteins. Related to Table 1. 
 
A. PIR-1 Interactors identified in PIR-1::GFP IP Using Gravid Adult Worms 
Protein Amino Acid Number Spectral Countsa Protein Coverage  
PIR-1 233 52  44.2% 
DCR-1 1910 132 31.9% 
RRF-3 1765 67 18.5% 
DRH-3 1119 61 23.9% 
ERI-5 (Y38F2AR.1a)
b 531 24 22.0% 
RDE-4 385 13 34.5% 
ERI-3 (W09B6.3a)
b 578 15 9.2% 
ERI-1 (T07A9.5b)
b,c 582 6 4.5%  
B. PIR-1 Interactors identified in PIR-1::3xFlag IP Using Gravid Adult Worms  




c 233 9 17.6% 
DCR-1 1910 24 8.6% 
RRF-3 1765 12 5.5% 
DRH-3 1119 15 7.1% 
RDE-4
c 385  8 15.1% 
a
The number of tandem mass spectra matching peptides derived from each protein. 
b
Only the isoform with the most counts is shown. 
c







Table S2. C. elegans strains used in this study. Related to Figure 2-4. 
W064 avr-14(ad1302) I; pir-1(tm3198)/mnC1*[In[Psur-5::gfp, Pmyo-2::avr-15] dpy-
10(e128) unc-52(e444)] II; avr-15(ad1051) glc-1(pk54::Tc1) V 
W058 In100[Ppir-1::pir-1::gfp::3'UTRpir-1]; pir-1(tm3198) II 
W178  In101 [Ppir-1::pir-1::3xflag::3'UTRpir-1]; pir-1(tm3198) II 
W250 In100 [Ppir-1::pir-1::gfp::3'UTR pir-1]; pir-1(tm3198) II; rde-4(ne337) III  
W251 In 100[Ppir-1::pir-1::gfp::3'UTR pir-1]; drh-3(ne4253) I; pir-1(tm3198) II 
W252 In 100[Ppir-1::pir-1::gfp::3'UTR pir-1]; pir-1(tm3198)II; dcr-1(ok247) III 
W253 In 100[Ppir-1::pir-1::gfp::3'UTR pir-1]; pir-1(tm3198) II; eri-1 (mg366) IV 
W254 pir1(tm3198) II; unc-119(ed3) III; In100[pir-1::gfp, Cb-unc-119(+)]; In102[pgl-
1::rfp, Cb-unc-119(+)] 
W255 pir1(tm3198)/mnC1* II; unc-119(ed3) III; In102[pgl-1::rfp, Cb-unc-119(+)] 
NL2099 rrf-3(pk1426) II 
CB4108 fog-2(q71) V 
W180 avr-14(ad1302) I; pir1(wg1000::C150S)/mnC1*[In[Psur-5::gfp, Pmyo-2::avr-15] 
dpy-10(e128) unc-52(e444)] II; avr-15(ad1051) glc-1(pk54::Tc1) V 
 
 
 
